Time filter

Source Type

Timisoara, Romania

The Victor Babeș University of Medicine and Pharmacy, Timișoara is located in Timişoara, Romania. Wikipedia.

Antoniu S.A.,Victor Babes University of Medicine and Pharmacy Timisoara
International Journal of COPD

In chronic obstructive pulmonary disease (COPD) the infammation occurring in the airways and in other lung tissues is complex and is orchestrated by various mediators including the isoenzyme 4 of the phosphodiesterases family (PDE4), which contributes to bronchoconstriction and infammation. Various PDE4 inhibitors have been evaluated as potential therapies in asthma or COPD but among these only rofumilast have been authorized in Europe to be used in patients with severe COPD as an add-on to the bronchodilator therapy. This review discusses the existing preclinical and clinical data supporting the use of rofumilast for this therapeutic indication and tackles some of the pending issues related to PDE4 in general and to rofumilast in particular. © 2011 Antoniu, publisher and licensee Dove Medical Press Ltd. Source

Mozos I.,Victor Babes University of Medicine and Pharmacy Timisoara
World Journal of Hepatology

Interactions between the functioning of the heart and the liver have been described, with heart diseases affecting the liver, liver diseases affecting the heart, and conditions that simultaneously affect both. The heart is one of the most adversely affected organs in patients with liver cirrhosis. For example, arrhythmias and electrocardiographic changes are observed in patients with liver cirrhosis. The risk for arrhythmia is influenced by factors such as cirrhotic cardiomyopathy, cardiac ion channel remodeling, electrolyte imbalances, impaired autonomic function, hepatorenal syndrome, metabolic abnormalities, advanced age, inflammatory syndrome, stressful events, impaired drug metabolism and comorbidities. Close monitoring of cirrhotic patients is needed for arrhythmias, particularly when QT intervalprolonging drugs are given, or if electrolyte imbalances or hepatorenal syndrome appear. Arrhythmia risk may persist after liver transplantation due to possible QT interval prolongation, persistence of the parasympathetic impairment, post-transplant reperfusion and chronic immunosuppression, as well as consideration of the fact that the transplant itself is a stressful event for the cardiovascular system. The aims of the present article were to provide a review of the most important data regarding the epidemiology, pathophysiology, and biomarkers of arrhythmia risk in patients with liver cirrhosis, to elucidate the association with long-term outcome, and to propose future research directions. © The Author(s) 2015. Published by Baishideng Publishing Group Inc. Source

Antoniu S.A.,Victor Babes University of Medicine and Pharmacy Timisoara
Current Opinion in Molecular Therapeutics

In development by MedImmune LLC, under license from Genaera Corp, MEDI-528 is an injectable, humanized mAb against IL-9 for the potential treatment of asthma. In asthma, airway inflammation is usually adequately minimized with standard-of-care treatments, such as inhaled corticosteroids and leukotriene modifiers, but it is sometimes less responsive to such therapies and other anti-inflammatory approaches are required. Several T-helper cell type 2-derived cytokines, such as IL-4, -5, -9 and -13, play a major role in the development of disease pathogenic features in asthma, including airway eosinophilia, increased IgE production, mucus hypersecretion and airway hyperreactivity. As an IL-9 antagonist, MEDI-528 appears to inhibit a range of asthma pathogenic features in antigen-exposed mice. To date, clinical data are modest, although insufficient to judge the efficacy of the drug in humans, and larger and longer-term clinical trials are required. MEDI-528, along with other anticytokine therapies targeting different ILs, remains under investigation in early-phase trials for asthma. Time will tell if this form of therapy can be used as an add-on to less efficacious anti-inflammatory therapy or can replace the existing anti-inflammatory therapies in the treatment of asthma. © Thomson Reuters (Scientific) Ltd. Source

Antoniu S.A.,Victor Babes University of Medicine and Pharmacy Timisoara
Expert Opinion on Biological Therapy

In asthma and chronic obstructive pulmonary disease (COPD), the inflammation in the airways cannot always be controlled with conventional therapies, such as inhaled corticosteroids. Addition of more specific anti-inflammatory therapies, such as monoclonal antibodies, against inflammation pathways might improve the disease outcome. Areas covered: This review individually discusses the major inflammation pathways and their potential blocking monoclonal antibodies in asthma and COPD. Expert opinion: The current use of omalizumab in asthma provides a good example on the potential therapeutic role of monoclonal antibodies in both asthma and COPD. There are many other monoclonal antibodies which are currently investigated as possible therapies in these diseases. The identification of the disease subsets in which such antibodies might exert the maximum benefit opens the door for personalized medicine and for targeted biological therapy in asthma and COPD. © 2013 Informa UK, Ltd. Source

Anatomical terminology is the foundation of medical terminology and it is important that doctors and scientists throughout the world use the same name for each structure. It is also important that the anatomical terms for a specific anatomical structure are presented in a logical order. To eliminate confusion, it is crucial that the same name is not attributed to two or more anatomical elements. However, the term artery of caudate lobe is used for two distinct anatomic elements with different origins (right/left branch of hepatic proper artery). Also, I draw attention to the incorrect positioning of right/left duct of caudate lobe in the description of terms homologated for the intrahepatic bile duct system. These proposals to amend the terminology in the liver anatomy are a necessary step in the evolution of the Terminologia Anatomica. © 2010 Springer-Verlag. Source

Discover hidden collaborations